5854-78-4Relevant articles and documents
Method for continuously producing O-tert-butyl-L-threonine tert-butyl ester
-
Paragraph 0028; 0030-0032; 0034-0036; 0038-0040; 0042, (2020/03/06)
The invention relates to a method for continuously producing O-tert-butyl-L-threonine tert-butyl ester. By selecting ZSM-5 supported silicotungstic acid as a catalyst and adopting a mode of connectingtwo tubular reactions in series, the invention provides the method for continuously producing O-tert-butyl-L-threonine tert-butyl ester, wherein the method is suitable for industrial production, theyield of the preparation method is greater than 80%, the purity is greater than 99%, and the preparation method is simple in process and suitable for industrial production requirements.
An efficient synthesis of tert-butyl ethers/esters of alcohols/amino acids using methyl tert-butyl ether
Mallesha,Prahlada Rao,Suhas,Channe Gowda
experimental part, p. 641 - 645 (2012/02/15)
A facile synthesis of a wide variety of tert-butyl ethers and tert-butyl ester derivatives under mild conditions is described. Alcohols etherified with tert-butyl methyl ether as tert-butyl source and solvent, in the presence of sulfuric acid. Many amino acid tert-butyl esters have been synthesized by this procedure. The reaction is simple, inexpensive, easily scaled up, and proceeds without observable racemization. A green method was developed for the deprotection of this group using Amberlite resin IR 120-H as catalyst.
Synthesis and biological activities of TAN-1511 analogues
Hida,Hayashi,Yukishige,Tanida,Kawamura,Harada
, p. 589 - 603 (2007/10/02)
TAN-1511 analogues were synthesized and their effects on the proliferation of bone marrow cells were examined. To exert potent activity the following conditions are necessary: the configuration of the 2-amino-6,7-dihydroxy-4-thiaheptanoic acid moiety must be (2R,6R), long chain acyl groups (C14 to C18) must be bound to both hydroxyl groups, the amino group must be free or acylated with the long chain fatty acid (ca. C14) and the peptide moiety must have glutamic acid as a component. Among the synthesized compounds, trisodium (2R,6R)-2-amino-6,7-bis (hexadecanoyloxy)-4-thiaheptanoyl glycyl glutamyl glutamate, which has improved solubility, was effective in experimental leukocytopenia in mice.